Evidence map›Paper›PMID 41302545›Full record

ArticleMolecules (Basel, Switzerland)2025

Assessment of ADC Higher Order Structure Through 2D NMR Analysis.

Emily M Grasso, Angela N Marquard, Zachary Sparta, David Fry, Nareshkumar Jain

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Emily M GrassoPlatform Innovation, NJ Bio, Inc., Princeton, NJ 08540, USA.ORCID 0000-0003-0014-4365
Angela N MarquardBioconjugation Research and Development, NJ Bio, Inc., Princeton, NJ 08540, USA.ORCID 0000-0003-1645-3816
Zachary SpartaPlatform Innovation, NJ Bio, Inc., Princeton, NJ 08540, USA.
David FryPlatform Innovation, NJ Bio, Inc., Princeton, NJ 08540, USA.
Nareshkumar JainGlobal Operations, NJ Bio, Inc., Princeton, NJ 08540, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibody-drug conjugates (ADCs) represent a growing class of important chemotherapeutic molecules. Our understanding of the physical properties of the antibody, linker, and payload is still quite limited, but a better understanding may lead to superior ADCs. Biomolecular NMR has shown promise in the characterization of antibody higher-order structure, suggesting that the same should be true for ADCs. We applied 2D NMR techniques to trastuzumab alone and to trastuzumab conjugated to MMAE and DXd linker-payloads at drug-antibody ratios (DAR) 2, 4, and 8 to assess the effects of drug conjugation on antibody higher-order structure. Trastuzumab alone generated high-quality NMR spectra under a variety of temperatures and concentrations. Spectra of low DAR species were remarkably similar both to each other and to the free antibody, except for notable new peaks in the spectra from the linker-payloads. Increasing DAR resulted in the disappearance of many well-dispersed peaks; at the highest DAR, both T-MMAE and T-DXd showed a global broadening of signals, although this effect was more extreme in T-MMAE. These spectra demonstrate the promise of biomolecular NMR to provide a direct window into the solution behavior of ADCs.

Indexed as

ImmunoconjugatesTrastuzumabHumansMagnetic Resonance SpectroscopyNuclear Magnetic Resonance, BiomolecularImmunoconjugatesTrastuzumabantibody-drug conjugatesbiomolecular NMRderuxtecandrug-antibody ratioMMAEtrastuzumab

Identifiers

PMID41302545
PMCPMC12655470

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.